Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aclaris Therapts (NQ: ACRS )

1.225 +0.015 (+1.24%)
Streaming Delayed Price Updated: 11:06 AM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Aclaris Therapts

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Cyclerion Therapeutics (NASDAQ:CYCN) stock increased by 37.46% to $4.33 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 9... 
Via Benzinga
Mid-Day Market Update: Coupa Software Drops After Q1 Results; NextDecade Shares Jump
Midway through trading Tuesday, the Dow traded down 0.09% to 34,598.11 while the NASDAQ rose 0.09% to 13,894.14. The S&P also fell, dropping 0.09% to 4,222.88. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Aclaris' ATI-1777 Aces Atopic Dermatitis Trial with Minimal Systemic Exposure
Aclaris Therapeutics Inc (NASDAQ: ACRS) has announced preliminary topline results from its Phase 2a trial evaluating ATI-1777 for moderate to severe atopic... 
Via Benzinga
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com. 
Via Investor's Business Daily
50 Stocks Moving In Tuesday's Mid-Day Session
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares jumped 72.4% to $20.55 amid increased retail investor interest in the stock. NextDecade Corporation (NASDAQ: NEXT... 
Via Benzinga
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021
Upgrades For Cerecor Inc (NASDAQ:CERC), Maxim Group upgraded the previous rating of Hold to Buy. In the fourth quarter, Cerecor showed an EPS of $0.19, compared to $0.10... 
Via Benzinga
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Aclaris Therapeutics, Inc... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.